Forging a long-term mutually beneficial business partnership, our in-licensing approach provides exciting opportunities to both our partners and us. We are actively pursuing unique domestic and international licensing opportunities in our core areas of expertise, which include antidotes & medical countermeasures, medical response during CBRNe emergencies and orphan drug products in various therapeutic areas. Specifically, we seek products complementing our existing line of products, as well as those of our parent company in Germany.
In addition to international in-licensing opportunities, Heyltex is interested in expanding its portfolio of development projects of medical and pharmaceutical products suitable for US Government homeland security funding programs. After evaluation, we can guide your project idea from the initial Tech-Watch meeting with the appropriate US Government grant funding authority through the proposal phase to contract and project execution.